Search
Search Results
-
Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
Background and aimChanging terminology of non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated fatty liver disease (MAFLD)...
-
Metabolic Syndrome and Periodontal Disease
Purpose of ReviewMetabolic syndrome is a systemic condition that has components such as obesity, dyslipidemia, hyperglycemia, and hypertension and is...
-
The Association Between Periodontal Disease and Non-Alcoholic Fatty Liver Disease is Linked to Metabolic Disorders
Purpose of ReviewNon-alcoholic fatty liver disease (NAFLD) is recognized as the most common cause of chronic liver disease. NAFLD regularly coexists...
-
A Systematic Approach to Treating Early Metabolic Disease and Prediabetes
At least 70% of US adults have metabolic disease. However, less is done to address early disease (e.g., overweight, obesity, prediabetes) versus...
-
Fatty Liver Disease: Enter the Metabolic Era
Purpose of ReviewThe goal of this review is to summarize the recent literature linking HIV to metabolic dysfunction-associated steatotic liver...
-
Metabolic Syndrome A Comprehensive Textbook
This comprehensive reference work presents an up-to-date survey of the current scientific understanding of the metabolic syndrome, as well as an...
-
The Global Epidemic of Metabolic Fatty Liver Disease
Purpose of ReviewThe objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associated...
-
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Purpose of ReviewMetabolic-associated fatty liver disease (MAFLD) is a condition of fat accumulation in the liver that occurs in the majority of...
-
Prevalence of Nonalcoholic Fatty Liver Disease [NAFLD] and Metabolic dysfunction associated Fatty Liver Disease [MAFLD] in patients with Irritable Bowel Syndrome [IBS]
Irritable Bowel Syndrome (IBS) and Nonalcoholic Fatty Liver Disease (NAFLD) are among most sought gastrointestinal and liver related conditions...
-
Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
Purpose of reviewTo update information about the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and...
-
Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns
Aims/hypothesisSodium–glucose co-transporter 2 (SGLT2) inhibitors (SGLT2i) are antihyperglycaemic drugs that protect the kidneys of individuals with...
-
Dietary Management of Metabolic Liver Disease
Purpose of ReviewMetabolic liver diseases encompass several different inherited conditions that affect metabolism and can lead to hepatic...
-
Metabolic Bone Disease in Preterm Neonates With Fetal Growth Restriction (FGR): A Prospective Cohort Study
ObjectivesTo study the association of fetal growth restriction (FGR) with metabolic bone disease in preterm neonates.
MethodologyThis prospective...
-
Metabolic risks remain a serious threat to cardiovascular disease: findings from the Global Burden of Disease Study 2019
Metabolic factors are major and controllable risk factors for cardiovascular diseases (CVD), and few studies have described this burden. We aim to...
-
Lipid metabolic reprogramming mediated by circulating Nrg4 alleviates metabolic dysfunction-associated steatotic liver disease during the early recovery phase after sleeve gastrectomy
BackgroundThe metabolic benefits of bariatric surgery that contribute to the alleviation of metabolic dysfunction-associated steatotic liver disease...
-
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
The historical use of the term non-alcoholic fatty liver disease (NAFLD) in obese/overweight children has been controversial as to the...
-
Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations
About 20% of adults worldwide have gallstones which are solid conglomerates in the biliary tree made of cholesterol monohydrate crystals, mucin,...
-
Intermuscular adipose tissue in metabolic disease
Intermuscular adipose tissue (IMAT) is a distinct adipose depot described in early reports as a ‘fatty replacement’ or ‘muscle fat infiltration’ that...
-
The Impact of Metabolic Bariatric Surgery on Cardiovascular Diseases in Patients with Metabolic Dysfunction–Associated Steatotic Liver Disease
PurposeThere is a strong association between metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity which are both important...
-
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
PurposeWe aimed to evaluate the prevalence of anxiety and depression traits in Italian patients with metabolic dysfunction-associated steatotic liver...
